Latest News
Details of the KEYNOTE-189 study have been announced by Merck (known as MSD outside the United States and Canada).
A study led by researchers at The Institute of Cancer Research (London, UK) has uncovered numerous ways of targeting prostate cancer.
Keep checking back throughout the conference, we will be updating this article with the biggest news headlines from the American Association for Cancer Research (AACR) Annual Meeting 2018 (April 14–18, IL, USA).
Journal Articles
What advancements have we witnessed in the field of immunotherapy for lung cancer and what does the future of this field look like? Find out in this article from Lung Cancer Management.
Discover cases studies of rare recurrences after adjuvant chemotherapy in this Editorial from Future Oncology.
Discover a comprehensive view of the molecular mechanisms involved in colorectal cancer pathogenesis.
Brain and neurologic
12 months of headlines: the most-read cancer news of 2017
Novel immunotherapy provides potential treatment for diffuse intrinsic pontine glioma
Breast
News round-up: 11th European Breast Cancer Conference
Treasure trove of 110 genes linked to breast cancer discovered
Novel blood test could quickly predict breast cancer patient’s response to palbociclib
Colorectal
Genetic fingerprints of every bowel cancer cell and bowel tumor revealed in novel study
Small, daily dose of Viagra may reduce colorectal cancer risk
Endocrine
Born to be bad: researchers identify the genetic roots of ‘killer' kidney cancers
Cyramza® meets primary endpoint of overall survival in liver cancer study
Advancing treatment options for medullary thyroid cancer: an interview with Jonathan Wadsley
Gastrointestinal
New blood test could detect eight types of cancer
Study links NF1 mutations to GIST tumors, highlighting the need for genetic testing
Genitourinary
Researchers uncover 80 potential ways of targeting prostate cancer
Novel strategy revealed for overcoming drug resistance in testicular cancer
Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer
Gynecologic
Case report - Pembrolizumab in recurrent advanced cervical squamous carcinoma
Head and neck
New test could diagnose esophageal cancer 8 years before symptoms appear
Novel liquid biopsy shows promise for early retinoblastoma diagnosis
Head and neck cancer: is there a future for combination immunotherapy?
Hematologic
The patient and clinician's perspective on the recent recommendation of ixazomib
What are the treatment options for myeloma? John Ellwood's story
Lung
KEYTRUDA® scores big again in NSCLC Phase III KEYNOTE-189 study
Exploring the CheckMate-227 study: an interview with Christiain Ottensmeier
Pancreatic
Smartphone app shows promise for pancreatic cancer detection
Will gemcitabine monotherapy be dethroned as the adjuvant chemotherapy in pancreatic adenocarcinoma?
Prostate
Prostate cancer deaths are not prevented by one-off PSA screening
‘Breakthrough’ prostate cancer test could cut diagnosis time from weeks to days
Breakaway cancerous cells successfully mapped and tracked with metal detection
Rare tumors
Larotrectinib shows 93% response rate in pediatric cancer trial
Skin
AACR 2018: highlights and the biggest news headlines
AACR 2018: Positive data announced for KEYTRUDA® in adjuvant melanoma
